A multicenter prospective study of carboplatin and paclitaxel for advanced thymic carcinoma: West Japan Oncology Group 4207L.
Koji Takeda
No relevant relationships to disclose
Fumihiko Hirai
No relevant relationships to disclose
Takeharu Yamanaka
No relevant relationships to disclose
Kenichi Taguchi
No relevant relationships to disclose
Haruko Daga
No relevant relationships to disclose
Junichi Shimizu
No relevant relationships to disclose
Yoshihito Kogure
No relevant relationships to disclose
Tatsuo Kimura
No relevant relationships to disclose
Kaoru Tanaka
No relevant relationships to disclose
Yasuo Iwamoto
No relevant relationships to disclose
Akira Ono
No relevant relationships to disclose
Hidefumi Sasaki
No relevant relationships to disclose
Junya Fukuoka
Employment or Leadership Position - Pathology Institute Corp. (U)
Stock Ownership - Pathology Institute Corp.
Kenichi Nishiyama
No relevant relationships to disclose
Takashi Seto
Honoraria - Bristol-Myers Squibb
Yukito Ichinose
Honoraria - Bristol-Myers Squibb
Kazuhiko Nakagawa
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Yoichi Nakanishi
No relevant relationships to disclose